These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 25700986)

  • 1. DNA methyl transferase 1 reduces expression of SRD5A2 in the aging adult prostate.
    Ge R; Wang Z; Bechis SK; Otsetov AG; Hua S; Wu S; Wu CL; Tabatabaei S; Olumi AF
    Am J Pathol; 2015 Mar; 185(3):870-82. PubMed ID: 25700986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5α-reductase 2.
    Wang Z; Hu L; Salari K; Bechis SK; Ge R; Wu S; Rassoulian C; Pham J; Wu CL; Tabatabaei S; Strand DW; Olumi AF
    J Pathol; 2017 Dec; 243(4):457-467. PubMed ID: 28940538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lessons learned about prostatic transformation from the age-related methylation of 5α-reductase type 2 gene.
    Isaacs JT
    Am J Pathol; 2015 Mar; 185(3):614-6. PubMed ID: 25700984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity-associated inflammation induces androgenic to estrogenic switch in the prostate gland.
    Xue B; Wu S; Sharkey C; Tabatabaei S; Wu CL; Tao Z; Cheng Z; Strand D; Olumi AF; Wang Z
    Prostate Cancer Prostatic Dis; 2020 Sep; 23(3):465-474. PubMed ID: 32029929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylated CpG dinucleotides in the 5-α reductase 2 gene may explain finasteride resistance in benign prostatic enlargement patients.
    Lin ZM; Fan DD; Jin S; Liu ZL; Niu YN
    Asian J Androl; 2021; 23(3):266-272. PubMed ID: 33243958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between 5-α reductase type 2 protein expression and methylation of 5-α reductase type 2 promotor gene of benign prostatic hyperplasia.
    Kang PM; Kim YJ; Seo WT; Kang SH; Kim TS; Chun BK; Seo WI; Jeong JY; Chung JI
    World J Urol; 2019 Apr; 37(4):709-718. PubMed ID: 30069579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced prostatic Esr1
    Sharkey C; Long X; Al-Faouri R; Strand D; Olumi AF; Wang Z
    J Pathol; 2024 Jul; 263(3):300-314. PubMed ID: 38606616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5α-reductase inhibitors and α-adrenergic receptor antagonists.
    Gu X; Na R; Huang T; Wang L; Tao S; Tian L; Chen Z; Jiao Y; Kang J; Zheng S; Xu J; Sun J; Qi J
    J Urol; 2013 Aug; 190(2):615-9. PubMed ID: 23499746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy.
    Wang Z; Deng T; Long X; Lin X; Wu S; Wang H; Ge R; Zhang Z; Wu CL; Taplin ME; Olumi AF
    PLoS One; 2020; 15(3):e0229754. PubMed ID: 32134978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and Obesity Promote Methylation and Suppression of 5α-Reductase 2: Implications for Personalized Therapy of Benign Prostatic Hyperplasia.
    Bechis SK; Otsetov AG; Ge R; Wang Z; Vangel MG; Wu CL; Tabatabaei S; Olumi AF
    J Urol; 2015 Oct; 194(4):1031-7. PubMed ID: 25916673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-κB and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance.
    Austin DC; Strand DW; Love HL; Franco OE; Grabowska MM; Miller NL; Hameed O; Clark PE; Matusik RJ; Jin RJ; Hayward SW
    Prostate; 2016 Aug; 76(11):1004-18. PubMed ID: 27197599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels.
    Rył A; Rotter I; Grzywacz A; Małecka I; Skonieczna-Żydecka K; Grzesiak K; Słojewski M; Szylińska A; Sipak-Szmigiel O; Piasecka M; Walczakiewicz K; Laszczyńska M
    Int J Environ Res Public Health; 2017 Oct; 14(11):. PubMed ID: 29084161
    [No Abstract]   [Full Text] [Related]  

  • 13. Upregulation of mir-1199-5p is associated with reduced type 2 5-α reductase expression in benign prostatic hyperplasia.
    Liu Z; Lin Z; Cao F; Jiang M; Jin S; Cui Y; Niu YN
    BMC Urol; 2022 Nov; 22(1):172. PubMed ID: 36344974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SRD5A2 gene expression inhibits cell migration and invasion in prostate cancer cell line via F-actin reorganization.
    Aggarwal S; Singh M; Kumar A; Mukhopadhyay T
    Mol Cell Biochem; 2015 Oct; 408(1-2):15-23. PubMed ID: 26092425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylation screening of primary prostate tumors identifies SRD5A2 and CYP11A1 as candidate markers for assessing risk of biochemical recurrence.
    Horning AM; Awe JA; Wang CM; Liu J; Lai Z; Wang VY; Jadhav RR; Louie AD; Lin CL; Kroczak T; Chen Y; Jin VX; Abboud-Werner SL; Leach RJ; Hernandez J; Thompson IM; Saranchuk J; Drachenberg D; Chen CL; Mai S; Huang TH
    Prostate; 2015 Nov; 75(15):1790-801. PubMed ID: 26332453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential expression of steroid 5alpha-reductase isozymes and association with disease severity and angiogenic genes predict their biological role in prostate cancer.
    Das K; Lorena PD; Ng LK; Lim D; Shen L; Siow WY; Teh M; Reichardt JK; Salto-Tellez M
    Endocr Relat Cancer; 2010 Sep; 17(3):757-70. PubMed ID: 20519274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracts of
    Song KH; Seo CS; Yang WK; Gu HO; Kim KJ; Kim SH
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33803357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of steroid 5-alpha reductase type 2 (Srd5a2) by sterol regulatory element binding proteins and statin.
    Seo YK; Zhu B; Jeon TI; Osborne TF
    Exp Cell Res; 2009 Nov; 315(18):3133-9. PubMed ID: 19500568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications.
    Guan M; Zhou X; Soulitzis N; Spandidos DA; Popescu NC
    Clin Cancer Res; 2006 Mar; 12(5):1412-9. PubMed ID: 16533763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Xenobiotic Biomarkers CYP1 Family in Preputial Tissue of Patients with Hypospadias and Phimosis and Its Association with DNA Methylation Level of SRD5A2 Minimal Promoter.
    Ohsako S; Aiba T; Miyado M; Fukami M; Ogata T; Hayashi Y; Mizuno K; Kojima Y
    Arch Environ Contam Toxicol; 2018 Feb; 74(2):240-247. PubMed ID: 29080015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.